Tags

Type your tag names separated by a space and hit enter

Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan.
J Clin Psychiatry. 2012 Apr; 73(4):e555-60.JC

Abstract

OBJECTIVE

To evaluate the possible association between benzodiazepine use and subsequent cancer risk in Taiwan.

METHOD

In this population-based retrospective cohort study, we used data from 1996 to 2000 from the Taiwanese National Health Insurance system to investigate the possible association between benzodiazepine use and cancer risk. The exposure cohort (mean age = 47.9 years, standard deviation [SD] = 17.3 years) consisted of 59,647 patients with benzodiazepine use. Each patient from the exposure cohort was randomly frequency-matched by age and sex to a person from the cohort with no benzodiazepine exposure (the comparison group; mean age = 46.4 years, SD = 17.8 years). Each study subject was followed until a diagnosis of cancer was made (according to ICD-9-CM) or until the time the subject was censored for loss to follow-up, death, or termination of insurance-or to the end of 2009. A Cox proportional hazard regression analysis was conducted to estimate the effects of benzodiazepine use on cancer risk.

RESULTS

In the group with benzodiazepine use, the overall risk of developing cancer was 19% higher than in the group without benzodiazepine exposure, and the difference between the groups was statistically significant (hazard ratio [HR] = 1.19; 99.6% CI, 1.08-1.32). With regard to individual types of cancer, the risk of developing liver cancer (HR = 1.45; 99.6% CI, 1.10-1.90), prostate cancer (HR = 1.72; 99.6% CI, 1.10-2.70), and bladder and kidney cancer (HR = 1.76; 99.6% CI, 1.16-2.67) was significantly higher for the benzodiazepine cohort.

CONCLUSIONS

This population-based study has shed light on a possible relationship between benzodiazepine use and increased cancer risk. Further large, thorough investigations are needed to confirm these findings.

Authors+Show Affiliations

Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22579162

Citation

Kao, Chia-Hung, et al. "Benzodiazepine Use Possibly Increases Cancer Risk: a Population-based Retrospective Cohort Study in Taiwan." The Journal of Clinical Psychiatry, vol. 73, no. 4, 2012, pp. e555-60.
Kao CH, Sun LM, Su KP, et al. Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. J Clin Psychiatry. 2012;73(4):e555-60.
Kao, C. H., Sun, L. M., Su, K. P., Chang, S. N., Sung, F. C., Muo, C. H., & Liang, J. A. (2012). Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. The Journal of Clinical Psychiatry, 73(4), e555-60. https://doi.org/10.4088/JCP.11m07333
Kao CH, et al. Benzodiazepine Use Possibly Increases Cancer Risk: a Population-based Retrospective Cohort Study in Taiwan. J Clin Psychiatry. 2012;73(4):e555-60. PubMed PMID: 22579162.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Benzodiazepine use possibly increases cancer risk: a population-based retrospective cohort study in Taiwan. AU - Kao,Chia-Hung, AU - Sun,Li-Min, AU - Su,Kuan-Pin, AU - Chang,Shih-Ni, AU - Sung,Fung-Chang, AU - Muo,Chih-Hsin, AU - Liang,Ji-An, PY - 2011/08/15/received PY - 2011/10/14/accepted PY - 2012/5/15/entrez PY - 2012/5/15/pubmed PY - 2012/7/14/medline SP - e555 EP - 60 JF - The Journal of clinical psychiatry JO - J Clin Psychiatry VL - 73 IS - 4 N2 - OBJECTIVE: To evaluate the possible association between benzodiazepine use and subsequent cancer risk in Taiwan. METHOD: In this population-based retrospective cohort study, we used data from 1996 to 2000 from the Taiwanese National Health Insurance system to investigate the possible association between benzodiazepine use and cancer risk. The exposure cohort (mean age = 47.9 years, standard deviation [SD] = 17.3 years) consisted of 59,647 patients with benzodiazepine use. Each patient from the exposure cohort was randomly frequency-matched by age and sex to a person from the cohort with no benzodiazepine exposure (the comparison group; mean age = 46.4 years, SD = 17.8 years). Each study subject was followed until a diagnosis of cancer was made (according to ICD-9-CM) or until the time the subject was censored for loss to follow-up, death, or termination of insurance-or to the end of 2009. A Cox proportional hazard regression analysis was conducted to estimate the effects of benzodiazepine use on cancer risk. RESULTS: In the group with benzodiazepine use, the overall risk of developing cancer was 19% higher than in the group without benzodiazepine exposure, and the difference between the groups was statistically significant (hazard ratio [HR] = 1.19; 99.6% CI, 1.08-1.32). With regard to individual types of cancer, the risk of developing liver cancer (HR = 1.45; 99.6% CI, 1.10-1.90), prostate cancer (HR = 1.72; 99.6% CI, 1.10-2.70), and bladder and kidney cancer (HR = 1.76; 99.6% CI, 1.16-2.67) was significantly higher for the benzodiazepine cohort. CONCLUSIONS: This population-based study has shed light on a possible relationship between benzodiazepine use and increased cancer risk. Further large, thorough investigations are needed to confirm these findings. SN - 1555-2101 UR - https://www.unboundmedicine.com/medline/citation/22579162/Benzodiazepine_use_possibly_increases_cancer_risk:_a_population_based_retrospective_cohort_study_in_Taiwan_ L2 - http://www.psychiatrist.com/jcp/article/pages/2012/v73n04/v73n0429.aspx DB - PRIME DP - Unbound Medicine ER -